Asia Pacific Point of Care Diagnostics Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Glucose Monitoring, Infectious Disease Testing, Cardio metabolic Testing, Pregnancy And Fertility Testing, Coagulation Testing, Tumor or Cancer Marker Testing, Cholesterol Testing, Urinalysis Testing, Hematology Testing, Thyroid Testing, and Others), Glucose Monitoring (Blood Glucose Meter, Lancet, and Strips), Infectious Disease Testing (HIV Testing, Influenza Testing, Sexually Transmitted Diseases Testing, Hepatitis C Virus Testing, Tropical Diseases Testing, Respiratory Infection Testing, Hospital Acquired Infections, and Others), Cardio Metabolic Testing (Cardiac Troponin (cTn) Test, Myoglobin Test, and Others), Purchase Mode (OTC and Prescription), Sample (Blood, Urine, and Others), End User (Healthcare Facilities, Homecare, and Others), and Healthcare Facilities (Hospitals and Clinics, Diagnostic Centers, and Others)
The Asia Pacific Point of Care (POC) Diagnostics Market is poised for significant growth, with projections indicating that it will reach approximately US$ 22,950.4 million by 2031, up from US$ 8,521.7 million in 2024. This growth trajectory reflects a robust compound annual growth rate (CAGR) of 15.3% from 2025 to 2031.
Executive Summary and Market Analysis
The POC diagnostics market in the Asia Pacific region is segmented geographically into key countries including China, Japan, India, South Korea, Australia, and other nations in the region. The market is expected to experience healthy growth driven by increasing investments from global players in emerging economies such as China and India, where there is a high demand for rapid and cost-effective diagnostic solutions. Governments in these countries are also implementing supportive policies and funding initiatives aimed at enhancing healthcare access and promoting the adoption of advanced diagnostic technologies.
The rapid expansion of healthcare infrastructure, coupled with a rise in chronic and infectious diseases, has further fueled the demand for effective point-of-care testing solutions. Recent technological advancements, an expanding healthcare coverage, and a large patient population present substantial opportunities for major players in the POC diagnostics market, allowing them to broaden their presence and product offerings across various countries.
Market Segmentation Analysis
The Asia Pacific POC diagnostics market is categorized by several factors:
For business expansion, market players are increasingly focusing on emerging nations like India, China, and Brazil, where there is a significant population affected by infectious diseases such as HIV. For instance, a report from the Press Information Bureau in 2023 indicated that approximately 2.5 million people in India are living with HIV, highlighting the urgent need for effective diagnostic solutions. The introduction of innovative products, such as Mylab's CoviSwift POC testing solution, exemplifies the potential for rapid testing capabilities in various settings, including small labs and rural areas.
Technological advancements in nanotechnology and genomics are also driving demand for diagnostics in the healthcare sector, leading to the development of more sophisticated point-of-care testing systems. These advancements are facilitating a shift towards personalized medicine and creating new opportunities in areas such as infectious disease testing, molecular oncology, and pharmacogenomics.
Country Insights
The Asia Pacific POC diagnostics market is further analyzed by country, with Japan holding the largest market share in 2024. Japan's aging population and the increasing prevalence of chronic diseases, such as diabetes and cancer, are significant factors contributing to market growth. The International Diabetes Federation reported that around 11 million adults in Japan were diabetic as of 2012, and awareness programs are being implemented to combat this issue. With a projected increase in the elderly population, the demand for advanced medical devices is expected to rise, presenting opportunities for international players in the market.
Competitive Landscape
Key players in the Asia Pacific POC diagnostics market include Siemens AG, Abbott Laboratories, F. Hoffmann-La Roche Ltd, bioMerieux SA, Bio-Rad Laboratories Inc, QIAGEN NV, Nova Biomedical Corporation, Polymer Technology Systems, Inc., and Danaher Corp. These companies are actively pursuing strategies such as market expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions to consumers.
Executive Summary and Market Analysis
The POC diagnostics market in the Asia Pacific region is segmented geographically into key countries including China, Japan, India, South Korea, Australia, and other nations in the region. The market is expected to experience healthy growth driven by increasing investments from global players in emerging economies such as China and India, where there is a high demand for rapid and cost-effective diagnostic solutions. Governments in these countries are also implementing supportive policies and funding initiatives aimed at enhancing healthcare access and promoting the adoption of advanced diagnostic technologies.
The rapid expansion of healthcare infrastructure, coupled with a rise in chronic and infectious diseases, has further fueled the demand for effective point-of-care testing solutions. Recent technological advancements, an expanding healthcare coverage, and a large patient population present substantial opportunities for major players in the POC diagnostics market, allowing them to broaden their presence and product offerings across various countries.
Market Segmentation Analysis
The Asia Pacific POC diagnostics market is categorized by several factors:
- By Product: The market includes segments such as Glucose Monitoring, Infectious Disease Testing, Cardio Metabolic Testing, Pregnancy and Fertility Testing, Coagulation Testing, Tumor Marker Testing, Cholesterol Testing, Urinalysis Testing, Hematology Testing, Thyroid Testing, and others. In 2024, Glucose Monitoring held the largest market share.
- By Glucose Monitoring: This segment is further divided into Blood Glucose Meters, Lancets, and Strips, with Strips leading the market share in 2024.
- By Infectious Disease Testing: This includes HIV Testing, Influenza Testing, Sexually Transmitted Diseases Testing, Hepatitis C Testing, and others, with Respiratory Infection Testing dominating the market share in 2024.
- By Cardio Metabolic Testing: This segment includes tests such as Cardiac Troponin (cTn) Tests, with Cardiac Troponin Tests holding the largest share in 2024.
- By Purchase Mode: The market is segmented into Over-the-Counter (OTC) and Prescription, with Prescription products leading in market share.
- By Sample Type: The market is divided into Blood, Urine, and others, with Blood samples being the most prevalent.
- By End User: The market includes Healthcare Facilities, Homecare, and others, with Healthcare Facilities holding the largest share.
- By Healthcare Facilities: This includes Hospitals, Clinics, and Diagnostic Centers, with Diagnostic Centers leading in market share in 2024.
For business expansion, market players are increasingly focusing on emerging nations like India, China, and Brazil, where there is a significant population affected by infectious diseases such as HIV. For instance, a report from the Press Information Bureau in 2023 indicated that approximately 2.5 million people in India are living with HIV, highlighting the urgent need for effective diagnostic solutions. The introduction of innovative products, such as Mylab's CoviSwift POC testing solution, exemplifies the potential for rapid testing capabilities in various settings, including small labs and rural areas.
Technological advancements in nanotechnology and genomics are also driving demand for diagnostics in the healthcare sector, leading to the development of more sophisticated point-of-care testing systems. These advancements are facilitating a shift towards personalized medicine and creating new opportunities in areas such as infectious disease testing, molecular oncology, and pharmacogenomics.
Country Insights
The Asia Pacific POC diagnostics market is further analyzed by country, with Japan holding the largest market share in 2024. Japan's aging population and the increasing prevalence of chronic diseases, such as diabetes and cancer, are significant factors contributing to market growth. The International Diabetes Federation reported that around 11 million adults in Japan were diabetic as of 2012, and awareness programs are being implemented to combat this issue. With a projected increase in the elderly population, the demand for advanced medical devices is expected to rise, presenting opportunities for international players in the market.
Competitive Landscape
Key players in the Asia Pacific POC diagnostics market include Siemens AG, Abbott Laboratories, F. Hoffmann-La Roche Ltd, bioMerieux SA, Bio-Rad Laboratories Inc, QIAGEN NV, Nova Biomedical Corporation, Polymer Technology Systems, Inc., and Danaher Corp. These companies are actively pursuing strategies such as market expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions to consumers.
1. INTRODUCTION
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. POINT OF CARE DIAGNOSTICS MARKET LANDSCAPE
4.1 PEST Analysis
5. ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. POINT OF CARE DIAGNOSTICS MARKET - ASIA PACIFIC MARKET ANALYSIS
6.1 Asia Pacific Point of Care Diagnostics Market Revenue (US$ Million), 2024 - 2031
6.2 Asia Pacific Point of Care Diagnostics Market Forecast and Analysis
7. ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY PRODUCT
7.1 Glucose Monitoring
7.1.1 Overview
7.1.2 Glucose Monitoring: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Infectious Disease Testing
7.2.1 Overview
7.2.2 Infectious Disease Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Cardio metabolic Testing
7.3.1 Overview
7.3.2 Cardio metabolic Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Pregnancy And Fertility Testing
7.4.1 Overview
7.4.2 Pregnancy And Fertility Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.5 Coagulation Testing
7.5.1 Overview
7.5.2 Coagulation Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.6 Tumor or Cancer Marker Testing
7.6.1 Overview
7.6.2 Tumor or Cancer Marker Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.7 Cholesterol Testing
7.7.1 Overview
7.7.2 Cholesterol Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.8 Urinalysis Testing
7.8.1 Overview
7.8.2 Urinalysis Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.9 Hematology Testing
7.9.1 Overview
7.9.2 Hematology Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.10 Thyroid Testing
7.10.1 Overview
7.10.2 Thyroid Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.11 Others
7.11.1 Overview
7.11.2 Others: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY GLUCOSE MONITORING
8.1 Blood Glucose Meter
8.1.1 Overview
8.1.2 Blood Glucose Meter: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Lancet
8.2.1 Overview
8.2.2 Lancet: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Strips
8.3.1 Overview
8.3.2 Strips: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY INFECTIOUS DISEASE TESTING
9.1 HIV Testing
9.1.1 Overview
9.1.2 HIV Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Influenza Testing
9.2.1 Overview
9.2.2 Influenza Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Sexually Transmitted Diseases Testing
9.3.1 Overview
9.3.2 Sexually Transmitted Diseases Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.4 Hepatitis C Virus Testing
9.4.1 Overview
9.4.2 Hepatitis C Virus Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.5 Tropical Diseases Testing
9.5.1 Overview
9.5.2 Tropical Diseases Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.6 Respiratory Infection Testing
9.6.1 Overview
9.6.2 Respiratory Infection Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.7 Hospital Acquired Infections
9.7.1 Overview
9.7.2 Hospital Acquired Infections: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY CARDIO METABOLIC TESTING
10.1 Cardiac Troponin (cTn) Test
10.1.1 Overview
10.1.2 Cardiac Troponin (cTn) Test: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 Myoglobin Test
10.2.1 Overview
10.2.2 Myoglobin Test: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 Others
10.3.1 Overview
10.3.2 Others: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY PURCHASE MODE
11.1 OTC
11.1.1 Overview
11.1.2 OTC: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2 Prescription
11.2.1 Overview
11.2.2 Prescription: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12. ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY SAMPLE
12.1 Blood
12.1.1 Overview
12.1.2 Blood: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.2 Urine
12.2.1 Overview
12.2.2 Urine: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.3 Others
12.3.1 Overview
12.3.2 Others: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13. ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY END USER
13.1 Healthcare Facilities
13.1.1 Overview
13.1.2 Healthcare Facilities: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.2 Homecare
13.2.1 Overview
13.2.2 Homecare: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.3 Others
13.3.1 Overview
13.3.2 Others: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14. ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY HEALTHCARE FACILITIES
14.1 Hospitals and Clinics
14.1.1 Overview
14.1.2 Hospitals and Clinics: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.2 Diagnostic Centers
14.2.1 Overview
14.2.2 Diagnostic Centers: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.3 Others
14.3.1 Overview
14.3.2 Others: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15. ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET - COUNTRY ANALYSIS
15.1 Asia Pacific
15.1.1 Asia Pacific Point of Care Diagnostics Market Revenue and Forecast and Analysis - by Country
15.1.1.1 Asia Pacific Point of Care Diagnostics Market Revenue and Forecast and Analysis - by Country
15.1.2.2 China: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.1.2.2.1 China: Asia Pacific Point of Care Diagnostics Market Share - by Product
15.1.2.2.2 China: Asia Pacific Point of Care Diagnostics Market Share - by Glucose Monitoring
15.1.2.2.3 China: Asia Pacific Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.1.2.2.4 China: Asia Pacific Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.1.2.2.5 China: Asia Pacific Point of Care Diagnostics Market Share - by Purchase Mode
15.1.2.2.6 China: Asia Pacific Point of Care Diagnostics Market Share - by Sample
15.1.2.2.7 China: Asia Pacific Point of Care Diagnostics Market Share - by End User
15.1.2.2.8 China: Asia Pacific Point of Care Diagnostics Market Share - by Healthcare Facilities
15.2.3.3 Japan: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.2.3.3.1 Japan: Asia Pacific Point of Care Diagnostics Market Share - by Product
15.2.3.3.2 Japan: Asia Pacific Point of Care Diagnostics Market Share - by Glucose Monitoring
15.2.3.3.3 Japan: Asia Pacific Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.2.3.3.4 Japan: Asia Pacific Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.2.3.3.5 Japan: Asia Pacific Point of Care Diagnostics Market Share - by Purchase Mode
15.2.3.3.6 Japan: Asia Pacific Point of Care Diagnostics Market Share - by Sample
15.2.3.3.7 Japan: Asia Pacific Point of Care Diagnostics Market Share - by End User
15.2.3.3.8 Japan: Asia Pacific Point of Care Diagnostics Market Share - by Healthcare Facilities
15.3.4.4 India: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.3.4.4.1 India: Asia Pacific Point of Care Diagnostics Market Share - by Product
15.3.4.4.2 India: Asia Pacific Point of Care Diagnostics Market Share - by Glucose Monitoring
15.3.4.4.3 India: Asia Pacific Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.3.4.4.4 India: Asia Pacific Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.3.4.4.5 India: Asia Pacific Point of Care Diagnostics Market Share - by Purchase Mode
15.3.4.4.6 India: Asia Pacific Point of Care Diagnostics Market Share - by Sample
15.3.4.4.7 India: Asia Pacific Point of Care Diagnostics Market Share - by End User
15.3.4.4.8 India: Asia Pacific Point of Care Diagnostics Market Share - by Healthcare Facilities
15.4.5.5 Australia: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.4.5.5.1 Australia: Asia Pacific Point of Care Diagnostics Market Share - by Product
15.4.5.5.2 Australia: Asia Pacific Point of Care Diagnostics Market Share - by Glucose Monitoring
15.4.5.5.3 Australia: Asia Pacific Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.4.5.5.4 Australia: Asia Pacific Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.4.5.5.5 Australia: Asia Pacific Point of Care Diagnostics Market Share - by Purchase Mode
15.4.5.5.6 Australia: Asia Pacific Point of Care Diagnostics Market Share - by Sample
15.4.5.5.7 Australia: Asia Pacific Point of Care Diagnostics Market Share - by End User
15.4.5.5.8 Australia: Asia Pacific Point of Care Diagnostics Market Share - by Healthcare Facilities
15.5.6.6 South Korea: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.5.6.6.1 South Korea: Asia Pacific Point of Care Diagnostics Market Share - by Product
15.5.6.6.2 South Korea: Asia Pacific Point of Care Diagnostics Market Share - by Glucose Monitoring
15.5.6.6.3 South Korea: Asia Pacific Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.5.6.6.4 South Korea: Asia Pacific Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.5.6.6.5 South Korea: Asia Pacific Point of Care Diagnostics Market Share - by Purchase Mode
15.5.6.6.6 South Korea: Asia Pacific Point of Care Diagnostics Market Share - by Sample
15.5.6.6.7 South Korea: Asia Pacific Point of Care Diagnostics Market Share - by End User
15.5.6.6.8 South Korea: Asia Pacific Point of Care Diagnostics Market Share - by Healthcare Facilities
15.6.7.7 Rest of APAC: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.6.7.7.1 Rest of APAC: Asia Pacific Point of Care Diagnostics Market Share - by Product
15.6.7.7.2 Rest of APAC: Asia Pacific Point of Care Diagnostics Market Share - by Glucose Monitoring
15.6.7.7.3 Rest of APAC: Asia Pacific Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.6.7.7.4 Rest of APAC: Asia Pacific Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.6.7.7.5 Rest of APAC: Asia Pacific Point of Care Diagnostics Market Share - by Purchase Mode
15.6.7.7.6 Rest of APAC: Asia Pacific Point of Care Diagnostics Market Share - by Sample
15.6.7.7.7 Rest of APAC: Asia Pacific Point of Care Diagnostics Market Share - by End User
15.6.7.7.8 Rest of APAC: Asia Pacific Point of Care Diagnostics Market Share - by Healthcare Facilities
17 INDUSTRY LANDSCAPE
17.1 Overview
17.2 New Product Development
17.3 Merger and Acquisition
17.4 Other Strategic Developments
18 COMPANY PROFILES
18.1 Siemens AG
18.1.1 Key Facts
18.1.2 Business Description
18.1.3 Products and Services
18.1.4 Financial Overview
18.1.5 SWOT Analysis
18.1.6 Key Developments
18.2 Abbott Laboratories
18.2.1 Key Facts
18.2.2 Business Description
18.2.3 Products and Services
18.2.4 Financial Overview
18.2.5 SWOT Analysis
18.2.6 Key Developments
18.3 F. Hoffmann-La Roche Ltd
18.3.1 Key Facts
18.3.2 Business Description
18.3.3 Products and Services
18.3.4 Financial Overview
18.3.5 SWOT Analysis
18.3.6 Key Developments
18.4 bioMerieux SA
18.4.1 Key Facts
18.4.2 Business Description
18.4.3 Products and Services
18.4.4 Financial Overview
18.4.5 SWOT Analysis
18.4.6 Key Developments
18.5 Bio-Rad Laboratories Inc
18.5.1 Key Facts
18.5.2 Business Description
18.5.3 Products and Services
18.5.4 Financial Overview
18.5.5 SWOT Analysis
18.5.6 Key Developments
18.6 QIAGEN NV
18.6.1 Key Facts
18.6.2 Business Description
18.6.3 Products and Services
18.6.4 Financial Overview
18.6.5 SWOT Analysis
18.6.6 Key Developments
18.7 Nova Biomedical Corporation
18.7.1 Key Facts
18.7.2 Business Description
18.7.3 Products and Services
18.7.4 Financial Overview
18.7.5 SWOT Analysis
18.7.6 Key Developments
18.8 Polymer Technology Systems, Inc. (PTS)
18.8.1 Key Facts
18.8.2 Business Description
18.8.3 Products and Services
18.8.4 Financial Overview
18.8.5 SWOT Analysis
18.8.6 Key Developments
18.9 Danaher Corp
18.9.1 Key Facts
18.9.2 Business Description
18.9.3 Products and Services
18.9.4 Financial Overview
18.9.5 SWOT Analysis
18.9.6 Key Developments
19. APPENDIX
19.1 About The Insight Partners
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. POINT OF CARE DIAGNOSTICS MARKET LANDSCAPE
4.1 PEST Analysis
5. ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. POINT OF CARE DIAGNOSTICS MARKET - ASIA PACIFIC MARKET ANALYSIS
6.1 Asia Pacific Point of Care Diagnostics Market Revenue (US$ Million), 2024 - 2031
6.2 Asia Pacific Point of Care Diagnostics Market Forecast and Analysis
7. ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY PRODUCT
7.1 Glucose Monitoring
7.1.1 Overview
7.1.2 Glucose Monitoring: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Infectious Disease Testing
7.2.1 Overview
7.2.2 Infectious Disease Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Cardio metabolic Testing
7.3.1 Overview
7.3.2 Cardio metabolic Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Pregnancy And Fertility Testing
7.4.1 Overview
7.4.2 Pregnancy And Fertility Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.5 Coagulation Testing
7.5.1 Overview
7.5.2 Coagulation Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.6 Tumor or Cancer Marker Testing
7.6.1 Overview
7.6.2 Tumor or Cancer Marker Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.7 Cholesterol Testing
7.7.1 Overview
7.7.2 Cholesterol Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.8 Urinalysis Testing
7.8.1 Overview
7.8.2 Urinalysis Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.9 Hematology Testing
7.9.1 Overview
7.9.2 Hematology Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.10 Thyroid Testing
7.10.1 Overview
7.10.2 Thyroid Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.11 Others
7.11.1 Overview
7.11.2 Others: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY GLUCOSE MONITORING
8.1 Blood Glucose Meter
8.1.1 Overview
8.1.2 Blood Glucose Meter: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Lancet
8.2.1 Overview
8.2.2 Lancet: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Strips
8.3.1 Overview
8.3.2 Strips: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY INFECTIOUS DISEASE TESTING
9.1 HIV Testing
9.1.1 Overview
9.1.2 HIV Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Influenza Testing
9.2.1 Overview
9.2.2 Influenza Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Sexually Transmitted Diseases Testing
9.3.1 Overview
9.3.2 Sexually Transmitted Diseases Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.4 Hepatitis C Virus Testing
9.4.1 Overview
9.4.2 Hepatitis C Virus Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.5 Tropical Diseases Testing
9.5.1 Overview
9.5.2 Tropical Diseases Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.6 Respiratory Infection Testing
9.6.1 Overview
9.6.2 Respiratory Infection Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.7 Hospital Acquired Infections
9.7.1 Overview
9.7.2 Hospital Acquired Infections: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY CARDIO METABOLIC TESTING
10.1 Cardiac Troponin (cTn) Test
10.1.1 Overview
10.1.2 Cardiac Troponin (cTn) Test: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 Myoglobin Test
10.2.1 Overview
10.2.2 Myoglobin Test: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 Others
10.3.1 Overview
10.3.2 Others: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY PURCHASE MODE
11.1 OTC
11.1.1 Overview
11.1.2 OTC: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2 Prescription
11.2.1 Overview
11.2.2 Prescription: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12. ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY SAMPLE
12.1 Blood
12.1.1 Overview
12.1.2 Blood: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.2 Urine
12.2.1 Overview
12.2.2 Urine: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.3 Others
12.3.1 Overview
12.3.2 Others: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13. ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY END USER
13.1 Healthcare Facilities
13.1.1 Overview
13.1.2 Healthcare Facilities: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.2 Homecare
13.2.1 Overview
13.2.2 Homecare: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.3 Others
13.3.1 Overview
13.3.2 Others: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14. ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET REVENUE ANALYSIS - BY HEALTHCARE FACILITIES
14.1 Hospitals and Clinics
14.1.1 Overview
14.1.2 Hospitals and Clinics: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.2 Diagnostic Centers
14.2.1 Overview
14.2.2 Diagnostic Centers: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.3 Others
14.3.1 Overview
14.3.2 Others: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15. ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET - COUNTRY ANALYSIS
15.1 Asia Pacific
15.1.1 Asia Pacific Point of Care Diagnostics Market Revenue and Forecast and Analysis - by Country
15.1.1.1 Asia Pacific Point of Care Diagnostics Market Revenue and Forecast and Analysis - by Country
15.1.2.2 China: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.1.2.2.1 China: Asia Pacific Point of Care Diagnostics Market Share - by Product
15.1.2.2.2 China: Asia Pacific Point of Care Diagnostics Market Share - by Glucose Monitoring
15.1.2.2.3 China: Asia Pacific Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.1.2.2.4 China: Asia Pacific Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.1.2.2.5 China: Asia Pacific Point of Care Diagnostics Market Share - by Purchase Mode
15.1.2.2.6 China: Asia Pacific Point of Care Diagnostics Market Share - by Sample
15.1.2.2.7 China: Asia Pacific Point of Care Diagnostics Market Share - by End User
15.1.2.2.8 China: Asia Pacific Point of Care Diagnostics Market Share - by Healthcare Facilities
15.2.3.3 Japan: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.2.3.3.1 Japan: Asia Pacific Point of Care Diagnostics Market Share - by Product
15.2.3.3.2 Japan: Asia Pacific Point of Care Diagnostics Market Share - by Glucose Monitoring
15.2.3.3.3 Japan: Asia Pacific Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.2.3.3.4 Japan: Asia Pacific Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.2.3.3.5 Japan: Asia Pacific Point of Care Diagnostics Market Share - by Purchase Mode
15.2.3.3.6 Japan: Asia Pacific Point of Care Diagnostics Market Share - by Sample
15.2.3.3.7 Japan: Asia Pacific Point of Care Diagnostics Market Share - by End User
15.2.3.3.8 Japan: Asia Pacific Point of Care Diagnostics Market Share - by Healthcare Facilities
15.3.4.4 India: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.3.4.4.1 India: Asia Pacific Point of Care Diagnostics Market Share - by Product
15.3.4.4.2 India: Asia Pacific Point of Care Diagnostics Market Share - by Glucose Monitoring
15.3.4.4.3 India: Asia Pacific Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.3.4.4.4 India: Asia Pacific Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.3.4.4.5 India: Asia Pacific Point of Care Diagnostics Market Share - by Purchase Mode
15.3.4.4.6 India: Asia Pacific Point of Care Diagnostics Market Share - by Sample
15.3.4.4.7 India: Asia Pacific Point of Care Diagnostics Market Share - by End User
15.3.4.4.8 India: Asia Pacific Point of Care Diagnostics Market Share - by Healthcare Facilities
15.4.5.5 Australia: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.4.5.5.1 Australia: Asia Pacific Point of Care Diagnostics Market Share - by Product
15.4.5.5.2 Australia: Asia Pacific Point of Care Diagnostics Market Share - by Glucose Monitoring
15.4.5.5.3 Australia: Asia Pacific Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.4.5.5.4 Australia: Asia Pacific Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.4.5.5.5 Australia: Asia Pacific Point of Care Diagnostics Market Share - by Purchase Mode
15.4.5.5.6 Australia: Asia Pacific Point of Care Diagnostics Market Share - by Sample
15.4.5.5.7 Australia: Asia Pacific Point of Care Diagnostics Market Share - by End User
15.4.5.5.8 Australia: Asia Pacific Point of Care Diagnostics Market Share - by Healthcare Facilities
15.5.6.6 South Korea: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.5.6.6.1 South Korea: Asia Pacific Point of Care Diagnostics Market Share - by Product
15.5.6.6.2 South Korea: Asia Pacific Point of Care Diagnostics Market Share - by Glucose Monitoring
15.5.6.6.3 South Korea: Asia Pacific Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.5.6.6.4 South Korea: Asia Pacific Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.5.6.6.5 South Korea: Asia Pacific Point of Care Diagnostics Market Share - by Purchase Mode
15.5.6.6.6 South Korea: Asia Pacific Point of Care Diagnostics Market Share - by Sample
15.5.6.6.7 South Korea: Asia Pacific Point of Care Diagnostics Market Share - by End User
15.5.6.6.8 South Korea: Asia Pacific Point of Care Diagnostics Market Share - by Healthcare Facilities
15.6.7.7 Rest of APAC: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.6.7.7.1 Rest of APAC: Asia Pacific Point of Care Diagnostics Market Share - by Product
15.6.7.7.2 Rest of APAC: Asia Pacific Point of Care Diagnostics Market Share - by Glucose Monitoring
15.6.7.7.3 Rest of APAC: Asia Pacific Point of Care Diagnostics Market Share - by Infectious Disease Testing
15.6.7.7.4 Rest of APAC: Asia Pacific Point of Care Diagnostics Market Share - by Cardio Metabolic Testing
15.6.7.7.5 Rest of APAC: Asia Pacific Point of Care Diagnostics Market Share - by Purchase Mode
15.6.7.7.6 Rest of APAC: Asia Pacific Point of Care Diagnostics Market Share - by Sample
15.6.7.7.7 Rest of APAC: Asia Pacific Point of Care Diagnostics Market Share - by End User
15.6.7.7.8 Rest of APAC: Asia Pacific Point of Care Diagnostics Market Share - by Healthcare Facilities
17 INDUSTRY LANDSCAPE
17.1 Overview
17.2 New Product Development
17.3 Merger and Acquisition
17.4 Other Strategic Developments
18 COMPANY PROFILES
18.1 Siemens AG
18.1.1 Key Facts
18.1.2 Business Description
18.1.3 Products and Services
18.1.4 Financial Overview
18.1.5 SWOT Analysis
18.1.6 Key Developments
18.2 Abbott Laboratories
18.2.1 Key Facts
18.2.2 Business Description
18.2.3 Products and Services
18.2.4 Financial Overview
18.2.5 SWOT Analysis
18.2.6 Key Developments
18.3 F. Hoffmann-La Roche Ltd
18.3.1 Key Facts
18.3.2 Business Description
18.3.3 Products and Services
18.3.4 Financial Overview
18.3.5 SWOT Analysis
18.3.6 Key Developments
18.4 bioMerieux SA
18.4.1 Key Facts
18.4.2 Business Description
18.4.3 Products and Services
18.4.4 Financial Overview
18.4.5 SWOT Analysis
18.4.6 Key Developments
18.5 Bio-Rad Laboratories Inc
18.5.1 Key Facts
18.5.2 Business Description
18.5.3 Products and Services
18.5.4 Financial Overview
18.5.5 SWOT Analysis
18.5.6 Key Developments
18.6 QIAGEN NV
18.6.1 Key Facts
18.6.2 Business Description
18.6.3 Products and Services
18.6.4 Financial Overview
18.6.5 SWOT Analysis
18.6.6 Key Developments
18.7 Nova Biomedical Corporation
18.7.1 Key Facts
18.7.2 Business Description
18.7.3 Products and Services
18.7.4 Financial Overview
18.7.5 SWOT Analysis
18.7.6 Key Developments
18.8 Polymer Technology Systems, Inc. (PTS)
18.8.1 Key Facts
18.8.2 Business Description
18.8.3 Products and Services
18.8.4 Financial Overview
18.8.5 SWOT Analysis
18.8.6 Key Developments
18.9 Danaher Corp
18.9.1 Key Facts
18.9.2 Business Description
18.9.3 Products and Services
18.9.4 Financial Overview
18.9.5 SWOT Analysis
18.9.6 Key Developments
19. APPENDIX
19.1 About The Insight Partners
LIST OF TABLES
Table 1. Asia Pacific Point of Care Diagnostics Market Segmentation
Table 3. Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 5. Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 6. Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 7. Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 8. Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 9. Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 10. Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 11. Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 12. Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 13. China: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 14. China: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 15. China: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 16. China: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 17. China: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 18. China: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 19. China: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 20. China: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 21. Japan: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 22. Japan: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 23. Japan: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 24. Japan: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 25. Japan: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 26. Japan: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 27. Japan: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 28. Japan: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 29. India: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 30. India: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 31. India: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 32. India: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 33. India: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 34. India: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 35. India: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 36. India: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 37. Australia: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 38. Australia: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 39. Australia: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 40. Australia: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 41. Australia: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 42. Australia: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 43. Australia: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 44. Australia: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 45. South Korea: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 46. South Korea: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 47. South Korea: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 48. South Korea: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 49. South Korea: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 50. South Korea: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 51. South Korea: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 52. South Korea: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 53. Rest of APAC: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 54. Rest of APAC: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 55. Rest of APAC: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 56. Rest of APAC: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 57. Rest of APAC: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 58. Rest of APAC: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 59. Rest of APAC: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 60. Rest of APAC: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 1. Asia Pacific Point of Care Diagnostics Market Segmentation
Table 3. Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 5. Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 6. Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 7. Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 8. Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 9. Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 10. Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 11. Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 12. Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 13. China: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 14. China: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 15. China: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 16. China: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 17. China: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 18. China: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 19. China: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 20. China: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 21. Japan: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 22. Japan: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 23. Japan: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 24. Japan: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 25. Japan: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 26. Japan: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 27. Japan: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 28. Japan: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 29. India: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 30. India: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 31. India: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 32. India: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 33. India: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 34. India: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 35. India: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 36. India: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 37. Australia: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 38. Australia: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 39. Australia: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 40. Australia: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 41. Australia: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 42. Australia: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 43. Australia: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 44. Australia: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 45. South Korea: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 46. South Korea: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 47. South Korea: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 48. South Korea: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 49. South Korea: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 50. South Korea: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 51. South Korea: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 52. South Korea: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
Table 53. Rest of APAC: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 54. Rest of APAC: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Glucose Monitoring
Table 55. Rest of APAC: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infectious Disease Testing
Table 56. Rest of APAC: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cardio Metabolic Testing
Table 57. Rest of APAC: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Purchase Mode
Table 58. Rest of APAC: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Sample
Table 59. Rest of APAC: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 60. Rest of APAC: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Healthcare Facilities
LIST OF FIGURES
Figure 1. Asia Pacific Point of Care Diagnostics Market Segmentation - Country
Figure 2. PEST Analysis
Figure 4. Asia Pacific Point of Care Diagnostics Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Asia Pacific Point of Care Diagnostics Market Revenue (US$ Million), 2024 - 2031
Figure 7. Asia Pacific Point of Care Diagnostics Market Share (%) - by Product, 2024 and 2031
Figure 8. Glucose Monitoring: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Infectious Disease Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Cardio metabolic Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Pregnancy And Fertility Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Coagulation Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Tumor or Cancer Marker Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Cholesterol Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Urinalysis Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Hematology Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Thyroid Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Others: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Asia Pacific Point of Care Diagnostics Market Share (%) - by Glucose Monitoring, 2024 and 2031
Figure 20. Blood Glucose Meter: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Lancet: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. Strips: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. Asia Pacific Point of Care Diagnostics Market Share (%) - by Infectious Disease Testing, 2024 and 2031
Figure 24. HIV Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Influenza Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 26. Sexually Transmitted Diseases Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Hepatitis C Virus Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. Tropical Diseases Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 29. Respiratory Infection Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 30. Hospital Acquired Infections: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 31. Others: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 32. Asia Pacific Point of Care Diagnostics Market Share (%) - by Cardio Metabolic Testing, 2024 and 2031
Figure 33. Cardiac Troponin (cTn) Test: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 34. Myoglobin Test: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 35. Others: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 36. Asia Pacific Point of Care Diagnostics Market Share (%) - by Purchase Mode, 2024 and 2031
Figure 37. OTC: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 38. Prescription: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 39. Asia Pacific Point of Care Diagnostics Market Share (%) - by Sample, 2024 and 2031
Figure 40. Blood: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 41. Urine: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 42. Others: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 43. Asia Pacific Point of Care Diagnostics Market Share (%) - by End User, 2024 and 2031
Figure 44. Healthcare Facilities: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 45. Homecare: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 46. Others: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 47. Asia Pacific Point of Care Diagnostics Market Share (%) - by Healthcare Facilities, 2024 and 2031
Figure 48. Hospitals and Clinics: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 49. Diagnostic Centers: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 50. Others: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 51. Asia Pacific Point of Care Diagnostics Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 52. China: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 53. Japan: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 54. India: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 55. Australia: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 56. South Korea: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 57. Rest of APAC: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 1. Asia Pacific Point of Care Diagnostics Market Segmentation - Country
Figure 2. PEST Analysis
Figure 4. Asia Pacific Point of Care Diagnostics Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Asia Pacific Point of Care Diagnostics Market Revenue (US$ Million), 2024 - 2031
Figure 7. Asia Pacific Point of Care Diagnostics Market Share (%) - by Product, 2024 and 2031
Figure 8. Glucose Monitoring: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Infectious Disease Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Cardio metabolic Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Pregnancy And Fertility Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Coagulation Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Tumor or Cancer Marker Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Cholesterol Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Urinalysis Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Hematology Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Thyroid Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Others: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Asia Pacific Point of Care Diagnostics Market Share (%) - by Glucose Monitoring, 2024 and 2031
Figure 20. Blood Glucose Meter: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Lancet: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. Strips: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. Asia Pacific Point of Care Diagnostics Market Share (%) - by Infectious Disease Testing, 2024 and 2031
Figure 24. HIV Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Influenza Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 26. Sexually Transmitted Diseases Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Hepatitis C Virus Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. Tropical Diseases Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 29. Respiratory Infection Testing: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 30. Hospital Acquired Infections: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 31. Others: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 32. Asia Pacific Point of Care Diagnostics Market Share (%) - by Cardio Metabolic Testing, 2024 and 2031
Figure 33. Cardiac Troponin (cTn) Test: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 34. Myoglobin Test: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 35. Others: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 36. Asia Pacific Point of Care Diagnostics Market Share (%) - by Purchase Mode, 2024 and 2031
Figure 37. OTC: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 38. Prescription: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 39. Asia Pacific Point of Care Diagnostics Market Share (%) - by Sample, 2024 and 2031
Figure 40. Blood: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 41. Urine: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 42. Others: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 43. Asia Pacific Point of Care Diagnostics Market Share (%) - by End User, 2024 and 2031
Figure 44. Healthcare Facilities: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 45. Homecare: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 46. Others: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 47. Asia Pacific Point of Care Diagnostics Market Share (%) - by Healthcare Facilities, 2024 and 2031
Figure 48. Hospitals and Clinics: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 49. Diagnostic Centers: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 50. Others: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 51. Asia Pacific Point of Care Diagnostics Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 52. China: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 53. Japan: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 54. India: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 55. Australia: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 56. South Korea: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 57. Rest of APAC: Asia Pacific Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
